au.\*:("ATKINS, Helen S")
Results 1 to 18 of 18
Selection :
Towards a Brucella vaccine for humansPERKINS, Stuart D; SMITHER, Sophie J; ATKINS, Helen S et al.FEMS microbiology reviews. 2010, Vol 34, Num 3, pp 379-394, issn 0168-6445, 16 p.Article
Potent antimicrobial peptides with selectivity for Bacillus anthracis over human erythrocytesDAWSON, Raymond M; FOX, Marc A; ATKINS, Helen S et al.International journal of antimicrobial agents (Print). 2011, Vol 38, Num 3, pp 237-242, issn 0924-8579, 6 p.Article
Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infectionATKINS, Helen S; SPENCER, Stephen; BREW, Simon D et al.International journal of antimicrobial agents (Print). 2009, Vol 34, Num 5, pp 474-476, issn 0924-8579, 3 p.Article
An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factorBAILLIE, Les W; HUWAR, Theresa B; ALTMANN, Danny M et al.Vaccine. 2010, Vol 28, Num 41, pp 6740-6748, issn 0264-410X, 9 p.Article
Small protective fragments of the Yersinia pestis V antigenVERNAZZA, Claire; LINGARD, Bry; FLICK-SMITH, Helen C et al.Vaccine. 2009, Vol 27, Num 21, pp 2775-2780, issn 0264-410X, 6 p.Article
Analysis of protection afforded by a Clostridium perfringens α-toxoid against heterologous clostridial phospholipases CNEESON, Brendan N; CLARK, Graeme C; ATKINS, Helen S et al.Microbial pathogenesis. 2007, Vol 43, Num 4, pp 161-165, issn 0882-4010, 5 p.Article
Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracisSTOKES, Margaret G. M; TITBALL, Richard W; ATKINS, Helen S et al.Infection and immunity. 2007, Vol 75, Num 4, pp 1827-1834, issn 0019-9567, 8 p.Article
The pathogen Pseudomonas aeruginosa negatively affects the attraction response of the nematode Caenorhabditis elegans to bacteriaLAWS, Thomas R; ATKINS, Helen S; ATKINS, Timothy P et al.Microbial pathogenesis. 2006, Vol 40, Num 6, pp 293-297, issn 0882-4010, 5 p.Article
Yersinia pestis TIR-domain protein forms dimers that interact with the human adaptor protein MyD88RANA, Rohini R; SIMPSON, Peter; MINGHAO ZHANG et al.Microbial pathogenesis. 2011, Vol 51, Num 3, pp 89-95, issn 0882-4010, 7 p.Article
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosisKENNY, Dermot J; SEFTON, Armine M; BROOKS, Timothy J. G et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 1, pp 87-89, issn 0924-8579, 3 p.Article
Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infectionATKINS, Helen S; SPENCER, Stephen; BREW, Simon D et al.International journal of antimicrobial agents (Print). 2009, Vol 34, Num 5, pp 471-473, issn 0924-8579, 3 p.Article
Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracisCOWAN, Graeme J. M; ATKINS, Helen S; JOHNSON, Linda K et al.Vaccine. 2007, Vol 25, Num 41, pp 7197-7205, issn 0264-410X, 9 p.Article
The identification and evaluation of ATP binding cassette systems in the intracellular bacterium Francisella tularensisATKINS, Helen S; DASSA, Elie; WALKER, Nicola J et al.Research in microbiology (Paris). 2006, Vol 157, Num 6, pp 593-604, issn 0923-2508, 12 p.Article
A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plagueSPEAR, Abigail M; RANA, Rohini R; JENNER, Dominic C et al.Microbiology (Reading). 2012, Vol 158, pp 1593-1606, issn 1350-0872, 14 p., 6Article
Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integrationLECKENBY, Matthew W; SPEAR, Abigail M; NEESON, Brendan N et al.Microbial pathogenesis. 2009, Vol 46, Num 4, pp 201-206, issn 0882-4010, 6 p.Article
Towards a human oral vaccine for anthrax : The utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategyBAILLIE, Leslie W. J; RODRIGUEZ, Ana L; MOORE, Stephen et al.Vaccine. 2008, Vol 26, Num 48, pp 6083-6091, issn 0264-410X, 9 p.Article
Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosisHARLAND, David N; CHU, Karen; TITBALL, Richard W et al.Infection and immunity. 2007, Vol 75, Num 8, pp 4173-4180, issn 0019-9567, 8 p.Article
The ABC transporter protein OppA provides protection against experimental Yersinia pestis infectionTANABE, Mikio; ATKINS, Helen S; HARLAND, David N et al.Infection and immunity. 2006, Vol 74, Num 6, pp 3687-3691, issn 0019-9567, 5 p.Article